- Home
- BAP vs ALC Comparison
BAP vs ALC Comparison
Compare BAP & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAP | ALC |
|---|---|---|
| Founded | 1889 | 1945 |
| Country | Peru | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5B | 32.6B |
| IPO Year | 1997 | 2002 |
Fundamental Metrics
Financial Performance| Metric | BAP | ALC |
|---|---|---|
| Price | $348.99 | $74.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 27 |
| Target Price | ★ $427.48 | $81.98 |
| AVG Volume (30 Days) | 304.4K | ★ 1.7M |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | ★ 4.27% | 0.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.76 | $6.56 |
| Revenue Next Year | $10.95 | $6.01 |
| P/E Ratio | ★ $12.91 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $230.45 | $61.84 |
| 52 Week High | $423.17 | $87.64 |
Technical Indicators
Market Signals| Indicator | BAP | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 35.18 | 64.58 |
| Support Level | $316.70 | $73.12 |
| Resistance Level | $360.23 | $76.27 |
| Average True Range (ATR) | 12.72 | 1.34 |
| MACD | -2.44 | 0.79 |
| Stochastic Oscillator | 12.00 | 70.63 |
Price Performance
Historical ComparisonAbout BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. The company operates in four business lines, including Universal Banking, Insurance and Retirement, Microfinance, and Investment Banking and Asset Management. Its subsidiaries include Banco de Credito del Peru, Prima AFP, Credicorp Capital, and others. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.